The New Standard of Weight Loss Best Seller

GLP-1 Medications

GLP-1 receptor agonists are a class of medications that mimic a natural gut hormone (glucagon-like peptide-1) that controls appetite, gastric emptying and insulin response. They are the most effective non-surgical fat-loss tools modern medicine has produced — clinical trials show 10–22% body-weight loss when used inside a structured program.

How it works

The mechanism

GLP-1 agonists slow stomach emptying, increase satiety signaling in the brain, and improve insulin sensitivity. The food-noise quiets, portion sizes shrink naturally, and you can finally hold a calorie deficit without willpower fatigue. Modern medications include semaglutide (Ozempic®, Wegovy®) and the dual GIP/GLP-1 agonist tirzepatide (Mounjaro®, Zepbound®).

Who it's for

Best candidates

  • Men with BMI ≥27 (or ≥30) wanting durable medical weight loss
  • Patients with metabolic syndrome, prediabetes, or insulin resistance
  • Men who repeatedly hit a plateau or rebound on diet alone

Protocol

Weekly subcutaneous injection, slow titration over 8–16 weeks to the lowest effective dose. Paired with a high-protein nutrition plan and resistance training to preserve muscle.

Timeline

Appetite suppression starts in week 1. Steady weight loss of 1–2% body weight per month is typical. Full-program loss of 10–22% by month 9–12.

What to expect

Side effects & considerations

Nausea, fatigue and constipation are most common in the first 2–4 weeks of each dose increase. Slow titration and a structured nutrition plan minimize these. Rare risk of pancreatitis and gallbladder issues — screened upfront.

Frequently asked

GLP-1 Medications FAQs

Pairs well with

Related treatments

Take the first step

Feel like yourself again — book a free consult.

15 minutes. No pressure. A clear plan if you want one.